ReproCell

ReproCell Days Inventory Outstanding

The Days Inventory Outstanding (DIO) of ReproCell (4978.T) as of Oct 31, 2026 is 82.77. In the previous year, Days Inventory Outstanding (DIO) was 73.21 — a change of 13.07% (higher).

Days Inventory Outstanding

82.77

YoY

13.07%

Last updated:

Days Inventory Outstanding (DIO) of ReproCell is 2026 82.77 . Days Inventory Outstanding (DIO) of ReproCell was 2025 73.21 . It decreases by 13.07% higher compared to the previous year.

The ReproCell Days Inventory Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Inventory Outstanding
Date
Days Inventory Outstanding
Jan 1, 2019
136.29 JPY
Jan 1, 2020
118.34 JPY
Jan 1, 2021
134.82 JPY
Jan 1, 2022
65.29 JPY
Jan 1, 2023
46.85 JPY
Jan 1, 2024
68.51 JPY
Jan 1, 2025
73.21 JPY
Jan 1, 2026
82.77 JPY
The ReproCell Days Inventory Outstanding history
YEARDays Inventory OutstandingYoY
82.77+13.07%
73.21+6.86%
68.51+46.23%
46.85-28.24%
65.29-51.58%
134.82+13.93%
118.34-13.17%
136.29+19.80%
113.77-11.38%
128.38+6.37%
120.68-59.04%
294.67+138.24%
123.69—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ReproCell Stock analysis

What does ReproCell do? ReproCell, Inc. is a company that was founded in 2003 and specializes in the research and manufacture of cell cultures. The company is based in Yokohama, Japan and operates worldwide. Its business model includes providing services and products to support research and development activities in the field of regenerative medicine and cell therapy. The company is divided into three main divisions: the Biorepository Division, which provides human cells and tissues for research purposes; the Cell Manufacturing Division, which develops production processes for cell therapy products; and the Drug Discovery Division, which supports drug development through screening and in vitro testing. ReproCell offers a variety of cell cultures, including stem cells from various sources, as well as related media, reagents, and tools for cultivation and application. In addition, the company offers services in cell therapy production, working closely with customers to provide customized and high-quality therapies. ReproCell also supports drug and compound research through screening and in vitro testing, with various platforms available for the identification and evaluation of new compounds. The company has a history of growth and has become a leading player in the field of cell culture and cell therapy production. In conclusion, ReproCell plays a significant role in regenerative medicine and cell therapy production, offering a wide range of products and services to support research and development in these areas. It is poised to continue its growth and contribute to the development of new therapies in the future. ReproCell is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ReproCell stock

Days Inventory Outstanding (DIO) of ReproCell is 82.77 in 2026.

Days Inventory Outstanding (DIO) of ReproCell changed from 73.21 to 82.77, representing a 13.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Inventory Outstanding (DIO) ReproCell since 2006 – with annual values, charts, and detailed analysis.

DIO measures the average number of days inventory is held before being sold. Lower values indicate more efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Inventory Outstanding (DIO)'s ReproCell with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Inventory Outstanding (DIO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Inventory Outstanding (DIO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — ReproCell

All Key Metrics — ReproCell